Tags

Type your tag names separated by a space and hit enter

Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States.
Cancer. 2014 Oct 15; 120(20):3200-7.C

Abstract

BACKGROUND

Human papillomavirus (HPV) infection is common among Hispanic males, but to the authors' knowledge little is known regarding HPV vaccination in this population. The authors examined the early adoption of the HPV vaccine among a national sample of Hispanic adolescent males.

METHODS

The authors analyzed provider-verified HPV vaccination data from the 2010 through 2012 National Immunization Survey-Teen (NIS-Teen) for Hispanic males aged 13 years to 17 years (n = 4238). Weighted logistic regression identified correlates of HPV vaccine initiation (receipt of ≥ 1 doses).

RESULTS

HPV vaccine initiation was 17.1% overall, increasing from 2.8% in 2010 to 31.7% in 2012 (P < .0001). Initiation was higher among sons whose parents had received a provider recommendation to vaccinate compared with those whose parents had not (53.3% vs 9.0%; odds ratio, 8.77 [95% confidence interval, 6.05-12.70]). Initiation was also higher among sons who had visited a health care provider within the previous year (odds ratio, 2.42; 95% confidence interval, 1.39-4.23). Among parents with unvaccinated sons, Spanish-speaking parents reported much higher intent to vaccinate compared with English-speaking parents (means: 3.52 vs 2.54; P < .0001). Spanish-speaking parents were more likely to indicate lack of knowledge (32.9% vs 19.9%) and not having received a provider recommendation (32.2% vs 17.7%) as the main reasons for not intending to vaccinate (both P < .05).

CONCLUSIONS

HPV vaccination among Hispanic adolescent males has increased substantially in recent years. Ensuring health care visits and provider recommendation will be key for continuing this trend. Preferred language may also be important for increasing HPV vaccination and addressing potential barriers to vaccination.

Authors+Show Affiliations

Division of Cancer Prevention and Control, College of Medicine, The Ohio State University, Columbus, Ohio; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; College of Public Health, The Ohio State University, Columbus, Ohio.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24948439

Citation

Reiter, Paul L., et al. "Early Adoption of the Human Papillomavirus Vaccine Among Hispanic Adolescent Males in the United States." Cancer, vol. 120, no. 20, 2014, pp. 3200-7.
Reiter PL, Brewer NT, Gilkey MB, et al. Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States. Cancer. 2014;120(20):3200-7.
Reiter, P. L., Brewer, N. T., Gilkey, M. B., Katz, M. L., Paskett, E. D., & Smith, J. S. (2014). Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States. Cancer, 120(20), 3200-7. https://doi.org/10.1002/cncr.28871
Reiter PL, et al. Early Adoption of the Human Papillomavirus Vaccine Among Hispanic Adolescent Males in the United States. Cancer. 2014 Oct 15;120(20):3200-7. PubMed PMID: 24948439.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States. AU - Reiter,Paul L, AU - Brewer,Noel T, AU - Gilkey,Melissa B, AU - Katz,Mira L, AU - Paskett,Electra D, AU - Smith,Jennifer S, Y1 - 2014/06/19/ PY - 2014/03/31/received PY - 2014/05/19/revised PY - 2014/05/22/accepted PY - 2014/6/21/entrez PY - 2014/6/21/pubmed PY - 2015/4/18/medline KW - HPV vaccine KW - Hispanic KW - National Immunization Survey-Teen (NIS-Teen) KW - cancer KW - human papillomavirus (HPV) SP - 3200 EP - 7 JF - Cancer JO - Cancer VL - 120 IS - 20 N2 - BACKGROUND: Human papillomavirus (HPV) infection is common among Hispanic males, but to the authors' knowledge little is known regarding HPV vaccination in this population. The authors examined the early adoption of the HPV vaccine among a national sample of Hispanic adolescent males. METHODS: The authors analyzed provider-verified HPV vaccination data from the 2010 through 2012 National Immunization Survey-Teen (NIS-Teen) for Hispanic males aged 13 years to 17 years (n = 4238). Weighted logistic regression identified correlates of HPV vaccine initiation (receipt of ≥ 1 doses). RESULTS: HPV vaccine initiation was 17.1% overall, increasing from 2.8% in 2010 to 31.7% in 2012 (P < .0001). Initiation was higher among sons whose parents had received a provider recommendation to vaccinate compared with those whose parents had not (53.3% vs 9.0%; odds ratio, 8.77 [95% confidence interval, 6.05-12.70]). Initiation was also higher among sons who had visited a health care provider within the previous year (odds ratio, 2.42; 95% confidence interval, 1.39-4.23). Among parents with unvaccinated sons, Spanish-speaking parents reported much higher intent to vaccinate compared with English-speaking parents (means: 3.52 vs 2.54; P < .0001). Spanish-speaking parents were more likely to indicate lack of knowledge (32.9% vs 19.9%) and not having received a provider recommendation (32.2% vs 17.7%) as the main reasons for not intending to vaccinate (both P < .05). CONCLUSIONS: HPV vaccination among Hispanic adolescent males has increased substantially in recent years. Ensuring health care visits and provider recommendation will be key for continuing this trend. Preferred language may also be important for increasing HPV vaccination and addressing potential barriers to vaccination. SN - 1097-0142 UR - https://www.unboundmedicine.com/medline/citation/24948439/Early_adoption_of_the_human_papillomavirus_vaccine_among_Hispanic_adolescent_males_in_the_United_States_ L2 - https://doi.org/10.1002/cncr.28871 DB - PRIME DP - Unbound Medicine ER -